(Q31156588)

29 June 2017

1 reference

title

The use of angiotensin-converting enzyme inhibitors in patients undergoing coronary artery bypass graft surgery (English)

1 reference

coronary artery bypass surgery

29 June 2017

0 references

0 references

author name string

Harold L Lazar

series ordinal

1

1 reference

29 June 2017

1 February 2005

1 reference

29 June 2017

Vascular Pharmacology

1 reference

29 June 2017

42

1 reference

29 June 2017

3

1 reference

29 June 2017

119-123

1 reference

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

29 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Differential action of angiotensin II and activity of angiotensin-converting enzyme in human bypass grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Tissue renin-angiotensin system in myocardial hypertrophy and failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Captopril, an ACE inhibitor, for optimizing reperfusion after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Captopril in cardioplegia and reperfusion: protective effects on the ischemic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Effects of angiotensin-converting enzyme inhibitor during warm blood cardioplegia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: possible mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Increased angiotensin-converting enzyme activity in coronary artery specimens from patients with acute coronary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Pretreatment with angiotensin-converting enzyme inhibitors attenuates ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Angiotensin-converting enzyme tissue activity in the diffuse in-stent restenotic plaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Angiotensin converting enzyme inhibitor therapy in severe postcardiotomy dysfunction: a prospective randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.01.012

10.1016/J.VPH.2005.01.012

7 January 2021

Identifiers

DOI

1 reference

29 June 2017

1 reference

PubMed ID

15792929